Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription 08.06.2026 1 BMC Neurol 2 Intern Med 1 J Nephrol 4 J Neurol 1 J Rheumatol 2 Lancet 7 Mult Scler 1 N Engl J Med 1 Neurology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. BUDUMURI VSK, G AK, Murugadoss H, Arun V, et al
   Patient-reported health utility in adults with myasthenia gravis: a systematic review and meta-analysis of EQ-5D outcomes.
   BMC Neurol. 2026 Jun 2. doi: 10.1186/s12883-026-05033.
   PubMed         Abstract available
   
   

   
   Intern Med

2. CHUNG SW, You JL, Ha YJ
   Immunoglobulin G4-related Disease with Solitary Nasopharynx Involvement Mimicking Nasopharyngeal Tumor.
   Intern Med. 2026;65:1566-1571.
   PubMed         Abstract available
   
   
3. SATO I, Onaka R, Fujiwara S, Hirasawa A, et al
   Reversible Cerebral Vasoconstriction Syndrome Associated with Autoimmune Hemolytic Anemia.
   Intern Med. 2026 May 30. doi: 10.2169/internalmedicine.7284.
   PubMed         Abstract available
   
   

   
   J Nephrol

4. PRAKASH TS, Kamat N, Janardhanan JJ
   Immune complex-mediated membranoproliferative glomerulonephritis following scabies infestation in a child: a rare association.
   J Nephrol. 2026 Jun 5:aajag062. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Neurol

5. BET MDA, Helmlinger B, Broeders TAA, Hechenberger SMC, et al
   Functional connectivity dynamics of monoaminergic circuits related to fatigue in multiple sclerosis.
   J Neurol. 2026;273:354.
   PubMed         Abstract available
   
   
6. BERGSLAND N, Burnham A, Dwyer MG, Bartnik A, et al
   Ultra-low-field MRI for bedside imaging of severe multiple sclerosis.
   J Neurol. 2026;273:364.
   PubMed         Abstract available
   
   
7. TEDONE N, Preziosa P, Pagani E, Meani A, et al
   Structural MRI signature of late- versus adult-onset multiple sclerosis: a multiparametric study.
   J Neurol. 2026;273:360.
   PubMed         Abstract available
   
   
8. HOWARD JF JR, Sacca F, Hoffmann S, Attarian S, et al
   Clinical effectiveness of efgartigimod in a broad population of patients with generalized myasthenia gravis: subgroup analyses from a randomized, double?blind, placebo?controlled, phase 3 trial (ADAPT).
   J Neurol. 2026;273:363.
   PubMed         Abstract available
   
   

   
   J Rheumatol

9. JAMES EA
   From Mouth to Joint: Citrullinated Bacteria in Driving Synovial Autoimmunity.
   J Rheumatol. 2026 Jun 1:jrheum.2026-0410. doi: 10.3899/jrheum.2026-0410.
   PubMed        
   
   

   
   Lancet

10. LEE PJ, Wong MG
    Endothelin antagonism in IgA nephropathy: promise ahead of proof?
    Lancet. 2026 Jun 4:S0140-6736(26)01094-9. doi: 10.1016/S0140-6736(26)01094.
    PubMed        
    
    
11. HEERSPINK HJL, Jardine MJ, Kohan DE, Lafayette R, et al
    Atrasentan in patients with IgA nephropathy (ALIGN): final 2.5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2026 Jun 4:S0140-6736(26)00960-8. doi: 10.1016/S0140-6736(26)00960.
    PubMed         Abstract available
    
    

    
    Mult Scler

12. BENALLEGUE N, Rollot F, Iaffaldano P, Lucisano G, et al
    A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.
    Mult Scler. 2026 Jun 1:13524585261446829. doi: 10.1177/13524585261446829.
    PubMed         Abstract available
    
    
13. CORREALE J, Marrodan M, Piedrabuena MA, Soman K, et al
    Microbiome-derived metabolites from vitamin B2 and B9 pathways modulate MAIT cells from multiple sclerosis patients.
    Mult Scler. 2026 Jun 1:13524585261447695. doi: 10.1177/13524585261447695.
    PubMed         Abstract available
    
    
14. LAULE C, Cohen-Adad J, Witt AA, De Luca GC, et al
    Spinal cord imaging for multiple sclerosis: Advances, priorities, and opportunities.
    Mult Scler. 2026 Jun 1:13524585261444600. doi: 10.1177/13524585261444600.
    PubMed         Abstract available
    
    
15. POSER PL, Gisevius B, Tokic M, Fisse AL, et al
    Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort.
    Mult Scler. 2026 Jun 1:13524585261446846. doi: 10.1177/13524585261446846.
    PubMed         Abstract available
    
    
16. SANDESJO F, McKay KA, Fink K, Piehl F, et al
    Treatment persistence in paediatric-onset multiple sclerosis: A Swedish nationwide registry study.
    Mult Scler. 2026 May 31:13524585261448789. doi: 10.1177/13524585261448789.
    PubMed         Abstract available
    
    
17. TALLANTYRE EC, Planchon SM, Howard H, Mays J, et al
    Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS).
    Mult Scler. 2026 May 31:13524585261449988. doi: 10.1177/13524585261449988.
    PubMed         Abstract available
    
    
18. SARASTE M, Nikkila T, Matilainen M, Hamalainen P, et al
    TSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosis.
    Mult Scler. 2026 May 31:13524585261446839. doi: 10.1177/13524585261446839.
    PubMed         Abstract available
    
    

    
    N Engl J Med

19. FERVENZA FC, Hou FF, Hao CM, Kirsztajn GM, et al
    Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy.
    N Engl J Med. 2026 Jun 5. doi: 10.1056/NEJMoa2602678.
    PubMed         Abstract available
    
    

    
    Neurology

20. YAO Y, Li Y, Liu J, Ji Z, et al
    Longitudinal Spinal Cord Atrophy in Patients With Neuromyelitis Optica Spectrum Disorder and Its Association With Rituximab Treatment.
    Neurology. 2026;106:e218120.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum